6-hydroxydopamine-induced nuclear factor-kappaB activation in PC12 cells

被引:39
作者
Blum, D
Torch, S
Nissou, MF
Verna, JM
机构
[1] ULB Erasme, Dept Neurosci, Neurophysiol Lab, B-1070 Brussels, Belgium
[2] CHU Michallon, INSERM, Equipe Mixte, F-38043 Grenoble 9, France
[3] Immunol Lab, F-38130 Echirolles, France
关键词
NF-kappaB; PC12; cells; 6-hydroxydopamine; bcl-2; Parkinson's disease;
D O I
10.1016/S0006-2952(01)00680-3
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The involvement of nuclear Factor-kappaB (NF-kappaB) transcription factor in PC12 cell death triggered by the dopaminergic neurotoxin 6-hydroxydopamine (6-OHDA) was investigated. Results show that oxidative stress generated by 6-OHDA activates NF-kappaB. When the NF-kappaB activation was inhibited by parthenolide, PC12 cell death induced by 6-OHDA was significantly increased, thus suggesting an involvement of this transcription factor in a protective mechanism against 6-OHDA toxicity. To further assess this hypothesis, we studied the involvement of NF-kappaB in the protective effect of two anti-apoptotic genes, bcl-2 and bfl-1. Although Bcl-2 and Bfl-1 expression normally protects PC12 cells from 6-OHDA, parthenolide strongly decreased the beneficial effects afforded by transgene expression. These results suggest: (1) that the transcription factor NF-kappaB is likely associated with the protection of catecholaminergic PC12 cells and (2) that the protective effects afforded by bcl-2 and bfl-1 expression may be dependent on NF-kappaB activation. (C) 2001 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:473 / 481
页数:9
相关论文
共 62 条
[21]   Insulin-like growth factor-1-mediated neuroprotection against oxidative stress is associated with activation of nuclear factor κB [J].
Heck, S ;
Lezoualc'h, F ;
Engert, S ;
Behl, C .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (14) :9828-9835
[22]   Sesquiterpene lactones specifically inhibit activation of NF-κB by preventing the degradation of IκB-α and IκB-β [J].
Hehner, SP ;
Heinrich, M ;
Bork, PM ;
Vogt, M ;
Ratter, F ;
Lehmann, V ;
Schulze-Osthoff, K ;
Dröge, W ;
Schmitz, ML .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (03) :1288-1297
[23]   RAPID PROTEOLYSIS OF I-KAPPA-B-ALPHA IS NECESSARY FOR ACTIVATION OF TRANSCRIPTION FACTOR NF-KAPPA-B [J].
HENKEL, T ;
MACHLEIDT, T ;
ALKALAY, I ;
KRONKE, M ;
BEN-NERIAH, Y ;
BAEUERLE, PA .
NATURE, 1993, 365 (6442) :182-185
[24]   Nuclear translocation of NF-kappa B is increased in dopaminergic neurons of patients with Parkinson disease [J].
Hunot, S ;
Brugg, B ;
Ricard, D ;
Michel, PP ;
Muriel, MP ;
Ruberg, M ;
Faucheux, BA ;
Agid, Y ;
Hirsch, EC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (14) :7531-7536
[25]   Inhibition of the expression of inducible cyclooxygenase and proinflammatory cytokines by sesquiterpene lactones in macrophages correlates with the inhibition of MAP kinases [J].
Hwang, D ;
Fischer, NH ;
Jang, BC ;
Tak, HY ;
Kim, JK ;
Lee, W .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 226 (03) :810-818
[26]  
Jellinger K, 1995, J NEURAL TRANSM-SUPP, P297
[27]   Temporal and subunit-specific modulations of the Rel/NF-kappa B transcription factors through CD28 costimulation [J].
KahnPerles, B ;
Lipcey, C ;
Lecine, P ;
Olive, D ;
Imbert, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (35) :21774-21783
[28]   Transcription factor NF-kappa B is activated in primary neurons by amyloid beta peptides and in neurons surrounding early plaques from patients with Alzheimer disease [J].
Kaltschmidt, B ;
Uherek, M ;
Volk, B ;
Baeuerle, PA ;
Kaltschmidt, C .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (06) :2642-2647
[29]   Inhibition of caspase cascade by HTLV-I Tax through induction of NF-κB nuclear translocation [J].
Kawakami, A ;
Nakashima, T ;
Sakai, H ;
Urayama, S ;
Yamasaki, S ;
Hida, A ;
Tsuboi, M ;
Nakamura, H ;
Ida, H ;
Migita, K ;
Kawabe, Y ;
Eguchi, K .
BLOOD, 1999, 94 (11) :3847-3854
[30]  
KUMAR R, 1995, J NEUROCHEM, V64, P1703